Antibodies against angiopoietins 1 and 2, and their use
US9512220B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2011 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Nov 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies against angiopoietins 1 and 2, and derivatives of these antibodies. More specifically, the present invention relates to therapeutic use of the antibodies and fragment thereof which specifically bind to angiopoietins 1 and 2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.